KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to -$16.2 million.

  • Opko Health's Cash from Financing Activities fell 10786.16% to -$16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$140.2 million, marking a year-over-year decrease of 16346.64%. This contributed to the annual value of $184.2 million for FY2024, which is 172935.5% up from last year.
  • Opko Health's Cash from Financing Activities amounted to -$16.2 million in Q3 2025, which was down 10786.16% from -$79.5 million recorded in Q2 2025.
  • Opko Health's Cash from Financing Activities' 5-year high stood at $206.1 million during Q3 2024, with a 5-year trough of -$79.5 million in Q2 2025.
  • Its 5-year average for Cash from Financing Activities is $4.5 million, with a median of -$2.1 million in 2024.
  • Per our database at Business Quant, Opko Health's Cash from Financing Activities surged by 969287.41% in 2024 and then tumbled by 365834.52% in 2025.
  • Quarter analysis of 5 years shows Opko Health's Cash from Financing Activities stood at $833000.0 in 2021, then surged by 1117.77% to $10.1 million in 2022, then tumbled by 136.98% to -$3.8 million in 2023, then tumbled by 978.97% to -$40.5 million in 2024, then surged by 59.96% to -$16.2 million in 2025.
  • Its Cash from Financing Activities was -$16.2 million in Q3 2025, compared to -$79.5 million in Q2 2025 and -$4.0 million in Q1 2025.